title: A Polymorphism within the Promoter of the Dopamine Receptor D1 (DRD1 -48A/G) Associates with Impaired Kidney Function in White Hypertensive Patients.
abstract: Dopamine DRD1 receptor regulates renal function and vascular resistance. It plays a role in the pathogenesis of hypertension in animal models. In humans, the DRD1 gene presents a A-48G polymorphism associated to hypertension in a Japanese population. To explore the role of this polymorphism on blood pressure and renal function in Caucasian hypertensive patients (H), we evaluated the allele frequencies in a populations of 697 H and 100 blood volunteers, and found no difference in the distribution of the alleles between the two groups (AA;AG;GG: 13%;50%;37%; and 12%; 51%;36% respectively). In H, we found a significant difference between AA and GG in serum creatinine (AA: 1.06±.08 mg/dl; GG:0.97±0.02 mg/dl, p<0.03). Treatment restored serum creatinine at levels comparable between genotypes (AA: 0.99±0.03 mg/dl; GG: 0.94±0.02 mg/dl, n.s.). To replicate the finding, in a case control study of 8 AA and 7 GG hypertensive patients matched for age, sex and body mass index, in pharmacological wash out for 30 days, we evaluated serum (Creatinine, Na, Uric Acid, Urea) and urinary (volume/24h, protein/24h, creatinine clearance/24h) biochemistry and renal hemodynamic assessed by ultrasound. Once again, the AA group showed higher serum creatinine, Na, Uric acid and urea, reduced creatinine clearance and a higher level of urinary protein excretion. These changes occurred while no differences were observed in diuresis and renal vascular resistances. In conclusions, the DRD1 A-48G polymorphism identifies a class of H that is prone to hypertension related kidney alterations.
authors.affiliation: Department of Medicina Clinica, Scienze Cardiovascolari ed Immunologiche, Federico II University, Naples, Italy.
authors.forename: Ersilia
authors.initials: E
authors.lastname: Cipolletta
authors.forename: Michele
authors.initials: M
authors.lastname: Ciccarelli
authors.forename: Raffaele
authors.initials: R
authors.lastname: Izzo
authors.forename: Rosa
authors.initials: R
authors.lastname: Finelli
authors.forename: Bruno
authors.initials: B
authors.lastname: Trimarco
authors.forename: Guido
authors.initials: G
authors.lastname: Iaccarino
references.citation: Hum Mol Genet. 1994 Jan;3(1):209
references.pmid: 8162032
references.citation: Am J Med Genet. 1996 Jul 26;67(4):424-8
references.pmid: 8837716
references.citation: J Hypertens. 2004 Nov;22(11):2117-22
references.pmid: 15480095
references.citation: Biol Psychiatry. 2002 Dec 15;52(12):1144-50
references.pmid: 12488059
references.citation: Am J Hypertens. 1996 Apr;9(4 Pt 1):400-5
references.pmid: 8722444
references.citation: J Clin Invest. 1992 Mar;89(3):789-93
references.pmid: 1531836
references.citation: Am J Hypertens. 2004 Dec;17(12 Pt 1):1184-7
references.pmid: 15607627
references.citation: Curr Med Chem Cardiovasc Hematol Agents. 2005 Jan;3(1):69-77
references.pmid: 15638746
references.citation: J Hypertens. 2005 Jul;23(7):1417-23
references.pmid: 15942466
references.citation: Arch Intern Med. 2001 Dec 10-24;161(22):2677-81
references.pmid: 11732932
references.citation: J Clin Invest. 1996 May 15;97(10):2283-8
references.pmid: 8636408
references.citation: Alcohol Clin Exp Res. 2003 Aug;27(8):1226-8
references.pmid: 12966314
references.citation: Am J Hypertens. 2004 Mar;17(3):240-4
references.pmid: 15001198
references.citation: N Engl J Med. 1963 Nov 14;269:1060-4
references.pmid: 14085064
references.citation: Hypertension. 1998 Aug;32(2):187-97
references.pmid: 9719042
references.citation: Eur J Pharmacol. 1998 Jul 24;353(2-3):149-58
references.pmid: 9726645
references.citation: Nature. 1990 Sep 6;347(6288):72-6
references.pmid: 2144334
references.citation: Am J Hum Genet. 1990 Nov;47(5):828-34
references.pmid: 1977312
references.citation: J Hypertens. 1998 May;16(5):601-8
references.pmid: 9797171
references.citation: Hypertension. 2000 Sep;36(3):395-9
references.pmid: 10988271
references.citation: J Hypertens. 2009 Nov;27(11):2121-58
references.pmid: 19838131
references.citation: Hypertension. 2000 Aug;36(2):183-6
references.pmid: 10948075
references.citation: Curr Opin Nephrol Hypertens. 2002 Jan;11(1):87-92
references.pmid: 11753092
references.citation: Nephron. 1976;16(1):31-41
references.pmid: 1244564
references.citation: Res Commun Mol Pathol Pharmacol. 1995 Mar;87(3):333-44
references.pmid: 7620826
references.citation: Am J Hypertens. 1990 Jun;3(6 Pt 2):96S-99S
references.pmid: 1974447
references.citation: J Hypertens. 1998 Nov;16(11):1667-76
references.pmid: 9856368
references.citation: Circulation. 1977 Apr;55(4):613-8
references.pmid: 138494
references.citation: Acta Physiol Scand. 2000 Jan;168(1):245-50
references.pmid: 10691808
references.citation: J Hypertens. 2003 May;21(5):821-48
references.pmid: 12714851
references.citation: Physiol Rev. 1998 Jan;78(1):189-225
references.pmid: 9457173
references.citation: Nephron Physiol. 2003;95(2):p19-27
references.pmid: 14610323
references.citation: J Am Soc Nephrol. 1997 May;8(5):813-6
references.pmid: 9176852
references.citation: Circulation. 1985 Jul;72(1):38-46
references.pmid: 3159505